Lanfang Li
Overview
Explore the profile of Lanfang Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
184
Citations
2126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cui Y, Hu G, Han X, Li W, Wang X, Qian Z, et al.
Hematol Oncol
. 2025 Mar;
43(2):e70050.
PMID: 40041930
Diffuse large B-cell lymphoma (DLBCL) is a biologically and clinically heterogeneous malignancy. Advances in transcriptomic and genetic profiling have significantly enhanced our understanding of the disease's intrinsic pathogenesis, uncovering numerous...
2.
Wang J, Jia J, Yu J, Liu J, Gao M, Liu H, et al.
Heliyon
. 2025 Mar;
11(4):e42497.
PMID: 40028613
Follicular lymphoma (FL) is a common B-cell lymphoma and typically affects the elderly population. It is urgently required to enhance our comprehension of disease-specific outcomes in elderly FL patients and...
3.
Li L, Guo Y, Jing W, Tang X, Zeng J, Hou Z, et al.
Adv Sci (Weinh)
. 2025 Feb;
:e2409397.
PMID: 39928529
Mammillary body (MB) is traditionally viewed as a structural node of an anatomic circuit for emotion and memory. However, little is known about its molecular and cellular organizations. Here, a...
4.
Wang B, Lu Y, Zhao J, Li L, Qiu L, Qian Z, et al.
Hematol Oncol
. 2025 Feb;
43(2):e70035.
PMID: 39912357
Primary lymphoma of the female genital tract (PLFGT) is a rare disease. The incidence is gradually increasing each year. There have been few reports about PLFGT, and most of them...
5.
Yu W, Li P, Zhou L, Yang M, Ye S, Zhu D, et al.
Blood
. 2025 Jan;
PMID: 39813680
Prizloncabtagene autoleucel (prizlon-cel), a novel bispecific chimeric antigen receptor (CAR) T-cell, targets and eliminates CD19/CD20 positive tumor cells. This phase 1, open-label study investigated the safety and efficacy of prizlon-cel...
6.
Wang L, Liu H, Li L
J Zhejiang Univ Sci B
. 2025 Jan;
25(12):1115-1119.
PMID: 39743298
Neurodegenerative diseases (NDDs), mainly including Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), and Alzheimer's disease (AD), are sporadic and rare genetic disorders of the central nervous system. A key feature...
7.
Feng Y, Liu X, Yu J, Song Z, Li L, Qiu L, et al.
Expert Opin Biol Ther
. 2024 Dec;
25(1):9-14.
PMID: 39702924
Introduction: Relapsed or refractory extranodal natural killer/T-cell lymphoma (R/R ENKTL) is a rare and aggressive subtype arising from natural killer or cytotoxic T-cells, predominantly affecting the nasal cavity and paranasal...
8.
Zhao P, Zhao S, Huang C, Li Y, Wang J, Xu J, et al.
Hematol Oncol
. 2024 Dec;
43(1):e70017.
PMID: 39641321
Polatuzumab vedotin plus R-CHP (Pola-R-CHP) is approved as a new standard first-line therapy for diffuse large B-cell lymphoma (DLBCL) based on the POLARIX trial. However, real-world data on its efficacy...
9.
Feng Y, Gao M, Xu X, Liu H, Lu K, Song Z, et al.
Eur J Cancer
. 2024 Nov;
213:115069.
PMID: 39489925
Background: Magnesium deficiency influences the activation and cytotoxicity of immune cells. Nevertheless, whether serum magnesium levels influence the clinical outcomes of immune checkpoint blockers (ICBs) treatment still remains ambiguous. There...
10.
Liu J, Gao F, Zhang T, Wang J, Li Z, Liu L, et al.
Br J Haematol
. 2024 Sep;
205(5):1815-1824.
PMID: 39327747
Some 'watch and wait' (W&W) FL patients suffer from rapid progression in a short term. Herein, we sought to identify these patients and also develop a risk score to screen...